Susan Hasty, Publisher
Table of Contents . . . March 3rd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Vaccine - Both dendritic cell cross-presentation pathways effective
HIV/AIDS Vaccine - Glycoconjugate vaccines effective in animals
HIV/AIDS Dementia - Endocannabinoid system protects glioma cells against Tat-induced cytotoxicity
HIV/AIDS Dementia - Insulin-like growth factor has protective effect
HIV/AIDS Dementia - U50,488 inhibits Tat-induced brain inflammation
HIV/AIDS Pathogenesis - Interleukin-15 overexpression prevents murine AIDS
AIDS Prevention - HIV-positive inmates frequently have unprotected sex before, after release
AIDS Therapy - 48-week study results presented comparing 908 to nelfinavir
AIDS Therapy - Early use of atazanavir may increase susceptibility to other PIs
AIDS Therapy - Experiment shows vaccine unlikely to give total protection from disease
AIDS Therapy - Global Phase III clinical trials launched for non-peptidic protease inhibitor
AIDS Therapy - Many promising new drugs on the horizon
AIDS Therapy - New antiretroviral drugs to expand HIV/AIDS therapies market potential
AIDS Therapy - Phase III data on ritonavir as therapy in PI-experienced patients "encouraging"
AIDS Therapy - Researchers test HIV/AIDS vaccine in Uganda
AIDS Treatment Failure - Resistance data on mutation patterns can help predict future options
Awards and Honors - AIDS researcher wins Veterans Affairs' Middleton Award
Cell Biology - Gene discovered by Temple researchers found to be multifunctional
Diagnostics - FDA accepts automated HIV-1 viral load test application for review
HIV/AIDS Coinfection - Multiple herpesvirus infections have limited effect on progression rate
HIV/AIDS Dementia - Cytomegalovirus infection may have protective effect
HIV/AIDS Enzymology - Novel HIV-1 integrase model may aid therapy research
HIV/AIDS Pathogenesis - Gag protein assembly in infected cells elucidated
HIV/AIDS Pathogenesis - Type I interferon producing cells play key role during infection
HIV/AIDS Pathogenesis - Viral protease has cytotoxic effects
HIV/AIDS Testing - AIDS testing project opens in East Baltimore
HIV/AIDS Therapy - Diverse repertoire of HIV-specific helper T cell clones seen after HAART
HIV/AIDS Therapy - Glucocorticoid treatment needed for patients with adrenal insufficiency
HIV/AIDS Therapy - Novel agents derived from Litsea verticillata
HIV/AIDS Therapy - Novel antiretroviral agent derived from Vicia faba seeds
HIV/AIDS Therapy - Protein-disulfide isomerase inhibitors block HIV cell entry
HIV/AIDS Therapy - Psychotherapy for pain may not be feasible
HIV/AIDS Therapy - Viral escape mutations seen after antiretroviral treatment suspension in macaques
HIV/AIDS Vaccine - Apoptotic, infected cells effective in animals
HIV/AIDS Vaccine - Dendritic cells loaded with viral antigens show promise
HIV/AIDS Vaccine - HIV-2 genetic library vaccines ineffective in animals
HIV/AIDS Vaccine - IL-2 increases CD4+ numbers but does not enhance responses to immunization
HIV/AIDS Vaccine - Researchers design CD4 mimic that inhibits HIV-1 entry
HIV/AIDS Vaccine - Therapeutic dendritic-cell vaccine effective against simian AIDS
HIV/AIDS Vaccine - Travelers spread HIV-1 genetic variants
HIV/AIDS Vaccine - Whole HIV-1 protein in liposomes prime CD8+ cells
Healthcare Costs - Prices of AIDS drugs in Central America cut more than half
Leukemia - Researchers discover how virus spreads through the body
Opportunistic Infection - Clinical trial of P. carinii pneumonia treatment completes enrollment
Opportunistic Infection - IL-10 modulates Pneumocystis carinii-induced lung damage
Opportunistic Infection - Interorgan differences seen in cytokine response to Penicillium marneffei
Physician Practice - Enhanced role of healthcare providers needed in national effort to fight HIV
Research Funding - University of Miami receives $2.5 million grant for children and families
Sexually Transmitted Diseases - Rush-Presbyterian-St. Luke's Medical Center licenses promising microbicide
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.